cancers Article Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS Yi-Ting Chen 1, Zi-Yi Huang 2, Han-Hsuan Tang 3, Wan-Ting Kuo 4, Shan-Ying Wu 4,5, Sheng-Hui Lan 4,6, Kai-Hsun Chang 1,3, Pin-Lun Lin 1, Ming-Fen Lee 7,8, Hung-Chi Cheng 9, Hsiao-Sheng Liu 4,10, Chi-Ying F. Huang 2,11 , Guan-Cheng Huang 12,* and Chun-Li Su 1,3,* 1 Department of Human Development and Family Studies, National Taiwan Normal University, Taipei 106, Taiwan;
[email protected] (Y.-T.C.);
[email protected] (K.-H.C.);
[email protected] (P.-L.L.) 2 Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan;
[email protected] (Z.-Y.H.);
[email protected] (C.-Y.F.H.) 3 Graduate Program of Nutrition Science, School of Life Science, National Taiwan Normal University, Taipei 106, Taiwan;
[email protected] 4 Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan;
[email protected] (W.-T.K.);
[email protected] (S.-Y.W.);
[email protected] (S.-H.L.);
[email protected] (H.-S.L.) 5 Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan 6 Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei 112, Taiwan 7 Department of Nutrition, China Medical University, Taichung 404, Taiwan;
[email protected] 8 Department of Nutrition and Health Sciences, Chang Jung Christian University, Tainan 711, Taiwan 9 Department